09:47     WEIGAO GROUP<08199> - Quarterly Results Announcement (1)            

    Shandong Weigao Group Medical Polymer Company Limited announced on 12/05/ 
    2005:                                                                     
    (stock code: 08199 )                                                      
                                                                              
    Year end date                         :31/12/2005                         
    Currency                              :RMB                                
    Auditors' report                      :N/A                                
    1st Quarterly Report Reviewed by      :Audit Committee                    
                                                                              
    Important Note :                                                          
                                                                              
    This result announcement form only contains extracted information from    
    and should be read in conjunction with the detailed results announcement  
    of the issuer, which can be viewed on the GEM website at                  
    http://www.hkgem.com                                                      
                                                                              
                                               (Unaudited)       (Unaudited)  
                                                  Current Last Corresponding  
                                                   Period            Period   
                                           from 01/01/2005   from 01/01/2004  
                                             to 31/03/2005     to 31/03/2004  
                                                   RMB'000           RMB'000  
                                                                              
    Turnover                              :        113,912            81,708  
    Profit/(Loss) from Operations         :         22,492            17,128  
    Finance cost                          :        (5,011)           (3,588)  
    Share of Profit/(Loss) of Associates  :            N/A              (58)  
    Share of Profit/(Loss) of Jointly                                         
             Controlled Entites           :             59               N/A  
    Profit/(Loss) after Taxation & MI     :         16,562            12,155  
    % Change Over the Last Period         :         +36.26%                   
    EPS / (LPS)                                                               
              Basic (in dollar)           :      RMB 0.019         RMB 0.018  
              Diluted (in dollar)         :            N/A               N/A  
    Extraordinary (ETD) Gain/(Loss)       :            N/A               N/A  
    Profit (Loss) after ETD Items         :         16,562            12,155  
    1st Quarter Dividends per Share       :            NIL               NIL  
    (specify if with other options)       :            N/A               N/A  
    B/C Dates for 1st Quarter Dividends   :            N/A                    
    Payable Date                          :            N/A                    
    B/C Dates for (-) General Meeting     :            N/A                    
    Other Distribution for Current Period :            NIL                    
    B/C Dates for Other Distribution      :            N/A                    
                                           (bdi: both days inclusive)         
                                                                              
    For and on behalf of                                                      
    Shandong Weigao Group Medical Polymer Company Limited                     
                                                                              
    Signature :                                                               
    Name      : Chong Tak Fat, Calvin                                         
    Title     : Company Secretary                                             
                                                                              
    Responsibility statement                                                  
                                                                              
    The directors of the Company (the "Directors") as at the date hereof      
    hereby collectively and individually accept full responsibility for the   
    accuracy of the information contained in this results announcement form   
    (the "Information") and confirm, having made all reasonable inquiries,    
    that to the best of their knowledge and belief the Information are        
    accurate and complete in all material respects and not misleading and     
    that there are no other matters the omission of which would make the      
    Information herein inaccurate or misleading.The Directors acknowledge     
    that the Stock Exchange has no responsibility whatsoever with regard to   
    the Information and undertake to indemnify the Exchange against all       
    liability incurred and all losses suffered by the Exchange in connection  
    with or relating to the Information.                                      
                                                                              
    Remarks:                                                                  
                                                                              
    1. Principal activities and basis of presentation                         
                                                                              
    Shandong Weigao Group Medical Polymer Company Limited (the "Company")     
    is a joint stock limited company incorporated in                          
    Shandong Province, the People's Republic of China (the "PRC")             
    on 28th December 2000 under the                                           
    approval document Lu Ti Gai Han Zi [2000] No. 39 issued by the            
    Reform Office of Shandong Province, its ultimate holding company          
    is Weigao Group Company Limited, a company                                
    registered in the PRC with limited liability.                             
                                                                              
    The Company is mainly engaged in the research and development,            
    production and sales of single-use medical devices.                       
                                                                              
    The H Shares of the Company were successfully listed on the               
    Growth Enterprise Market ("GEM") of The Stock Exchange of Hong Kong       
    Limited on 27th February 2004.                                            
                                                                              
    The financial statements have been prepared in accordance with            
    the accounting principles generally accepted in Hong Kong, the            
    Statements of Standards Accounting Practice of Hong Kong as               
    well as the disclosure requirements under the Companies                   
    Ordinance, and have been prepared on the basis of historical              
    cost.